Serological surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies is important to monitor population COVID-19 immunity. Dried blood spots (DBS) are a valuable method for serosurveys, particularly in remote settings and in children. We compared the measurement of SARS-CoV-2 spike-specific IgG in paired blood samples collected using standard venepuncture (serum) and the hemaPEN microsampling DBS device from children and adults. A total of 83 participants (10 months to 65 years of age), comprising COVID-positive and -negative participants, were recruited. Paired serum and DBS samples were assayed for SARS-CoV-2 receptor-binding domain (RBD) and Spike (S1) antibodies using an established in-house ELISA. RBD and S1 IgG concentrations of paired hemaPEN DBS eluates and serum samples were compared using a non-parametric Wilcoxon matched-pairs signed ranked test. A Pearson's correlation was used for RBD and S1 IgG concentrations and the level of agreement between the hemaPEN DBS eluates and serum samples was assessed by Bland-Altman analysis. A total of N = 41 adults (36 COVID-positive and 5 COVID-negative), and N = 42 children (37 COVID-positive, and 5 COVID-negative) have paired serum and DBS assayed. We found moderate to strong correlations between paired hemaPEN DBS eluates and serum SARS-CoV-2 IgG antibodies for RBD (r = 0.9472, < 0.0001) and S1 proteins (r = 0.6892, < 0.0001). Similar results were observed in both adult and paediatric populations. No significant differences in S1-specific IgG levels were observed in hemaPEN DBS samples stored for up to 35 weeks at room temperature. Eluted hemaPEN samples showed high specificity and sensitivity (100% and 89.89%, respectively) compared with serum. The use of the microsampling hemaPEN device for DBS sample collection is a feasible approach for assessing SARS-CoV-2 antibodies for serosurveillance studies, particularly in remote settings and in children.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11843976PMC
http://dx.doi.org/10.3390/antib14010013DOI Listing

Publication Analysis

Top Keywords

hemapen dbs
16
dbs eluates
12
eluates serum
12
dbs
9
hemapen
8
children adults
8
sars-cov-2 antibodies
8
remote settings
8
settings children
8
paired serum
8

Similar Publications

Serological surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies is important to monitor population COVID-19 immunity. Dried blood spots (DBS) are a valuable method for serosurveys, particularly in remote settings and in children. We compared the measurement of SARS-CoV-2 spike-specific IgG in paired blood samples collected using standard venepuncture (serum) and the hemaPEN microsampling DBS device from children and adults.

View Article and Find Full Text PDF
Article Synopsis
  • Dried blood spot (DBS) sampling faces challenges like varying haematocrit levels and chromatographic issues, prompting the use of commercial volumetric microsampling devices, which unfortunately require manual processing and aren't automated.
  • The study utilized an Agilent 7100 capillary electrophoresis (CE) instrument for automated processing of DBS samples collected via the hemaPEN® device, achieving precise liquid handling and repeatable results with blood sample analyses.
  • The analysis focused on creatinine levels, showing an excellent calibration curve and high throughput of over 12 DBSs per hour, while demonstrating that factors like sample aging and blood haematocrit levels did not significantly impact the results.
View Article and Find Full Text PDF
Article Synopsis
  • Osimertinib, a drug for non-small cell lung cancer (NSCLC), can cause toxicity, leading to the need for dose adjustments; this study aimed to measure osimertinib and its active metabolites in dried blood spots (DBS) using a specialized hemaPEN device and compare results to plasma measurements.
  • A validated method using ultrahigh-performance liquid chromatography-tandem mass spectrometry was developed to accurately quantify osimertinib and its metabolites from both plasma and DBS, demonstrating no significant bias linked to hematocrit levels in patient samples.
  • The study concluded that measuring these drugs in DBS is a reliable and easier alternative for therapeutic drug monitoring, showing similar results to those obtained
View Article and Find Full Text PDF

Validating blood microsampling for per- and polyfluoroalkyl substances quantification in whole blood.

J Chromatogr A

January 2024

Australian Laboratory for Emerging Contaminants, School of Chemistry, University of Melbourne, Victoria 3010, Australia. Electronic address:

Article Synopsis
  • Microsampling is a cost-effective and easy method for collecting blood samples that doesn't require specialized medical training.
  • Analysis of dried blood spots (DBS) provides a better understanding of how per- and polyfluoroalkyl substances (PFAS) are present in the body.
  • A study found that filtered protein precipitation was the best technique for extracting PFAS, successfully identifying 72 out of 75 PFAS and paving the way for more extensive human biomonitoring studies.
View Article and Find Full Text PDF

New perspectives for the therapeutic drug monitoring of tacrolimus: Quantification in volumetric DBS based on an automated extraction and LC-MS/MS analysis.

J Chromatogr B Analyt Technol Biomed Life Sci

May 2023

Service de Pharmacologie, toxicologie et pharmacovigilance, CHU Limoges, Limoges, France; INSERM UMR-1248 « Pharmacologie et Transplantation », Université Limoges, Limoges, France; FHU SUPORT, Limoges, France. Electronic address:

Volumetric microsampling devices have been developed for home-based capillary blood sampling and are now increasingly proposed for the therapeutic drug monitoring (TDM) of immunosuppressive drugs. Our objective was to validate a LC-MS/MS method for tacrolimus quantification based on both a manual and an automated extraction of dried blood spots (DBS) collected with a volumetric microsampling device. DBS collection was performed by placing a drop of whole blood (WB) pre-spiked with tacrolimus onto a sealing film and placing the hemaPEN® device (Trajan Scientific and Medical, Melbourne, Australia) into the drop according to the device specifications.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!